DOMAIN: PROTEOMICS, METABOLOMICS & MULTI-OMICS
PIPELINE #051
Bottom-Up DDA/DIA Quantitative Label-Free & TMT Mass Spectrometry Proteomics
Technical Scope: Peptide spectrum matching, FDR control, protein inference, missing-value imputation, batch correction, and differential protein abundance modeling.
Required Input Data & Formats
Raw Mass Spec Files (.raw / .mzML), Target-Decoy Protein FASTA (.fasta), Experimental Design & TMT Channel Matrix (.tsv).
Produced Output Files & Deliverables
Normalized Protein & Peptide Intensity Matrices (.tsv), Differential Protein Abundance Tables (.csv), Volcano, PCA & Pathway Enrichment Plots (.pdf), MultiQC.
Core Software Toolchain & Frameworks
DIA-NN, MSFragger / FragPipe, MaxQuant, Perseus, MSstats, limma, Prolfqua, nf-core/quantms.
Key Literature & Methodological References
Demichev et al. (2020) Nature Methods (DIA-NN); Kong et al. (2017) Nature Methods (MSFragger); Choi et al. (2014) Bioinformatics (MSstats); Dai et al. (2024) Nature Methods (quantms).
Application
“Proteins are the direct functional effectors of cellular phenotype and the primary targets of small-molecule and biologic drugs. Our Quantitative Proteomics pipeline processes both Data-Dependent (DDA/TMT) and Data-Independent Acquisition (DIA) mass spectrometry datasets using DIA-NN and MSFragger within the reproducible nf-core/quantms framework. We enforce strict 1% peptide and protein FDR thresholds, apply variance-stabilizing normalization and MNAR-aware imputation, and model differential protein abundance using MSstats and limma. You receive high-coverage protein quantification matrices and pathway-annotated biomarker panels ready for target validation.”
DOMAIN: PROTEOMICS, METABOLOMICS & MULTI-OMICS
PIPELINE #052
Phosphoproteomics & Post-Translational Modification (PTM) Kinase Activity Profiling
Technical Scope: Site-localization probability filtering, protein-abundance normalization of PTM sites, differential phosphorylation, and kinase-substrate enrichment.
Required Input Data & Formats
Enriched PTM Raw MS Files (.raw/.mzML), Matched Total Proteome Matrix (.tsv), Protein FASTA (.fasta), Experimental Design (.tsv).
Produced Output Files & Deliverables
Site-Localized PTM Intensity Matrix (Probability >0.75, .tsv), Differential Phosphosite Table (.csv), Inferred Kinase Activity Scores (KSEA/RoKAI, .pdf/.tsv).
Core Software Toolchain & Frameworks
MSFragger + PTMProphet, DIA-NN, PhosR, KSEAapp, RoKAI, decoupleR (PhosphoSitePlus/OmniPath), limma.
Key Literature & Methodological References
Kim et al. (2021) Cell Systems (PhosR); Yılmaz et al. (2021) Nature Communications (RoKAI); Shteynberg et al. (2019) Molecular & Cellular Proteomics (PTMProphet).
Application
“Signaling cascades operate on timescales of seconds to minutes via reversible protein phosphorylation, acetylation, and ubiquitination—events completely invisible to transcriptomics. Our Phosphoproteomics and PTM Profiling pipeline utilizes MSFragger and PTMProphet to guarantee confident single-residue site localization, normalizes phosphosite changes against matched total protein levels to distinguish true signaling flux from protein turnover, and infers upstream kinase activation using RoKAI and Kinase-Substrate Enrichment Analysis. Pinpoint active signaling pathways and resistance mechanisms for kinase inhibitor and targeted therapy programs.”
DOMAIN: PROTEOMICS, METABOLOMICS & MULTI-OMICS
PIPELINE #053
Immunopeptidomics & HLA-Presented Neoantigen Discovery
Technical Scope: Non-tryptic MS/MS search, HLA allele-specific binding affinity prediction, tumor-specific neoantigen prioritization, and immunogenicity scoring.
Required Input Data & Formats
HLA-IP Mass Spec Files (.raw/.mzML), Patient-Specific Mutated Proteome FASTA (from WGS/WES + RNA-Seq), Patient HLA-I/II Types (.tsv).
Produced Output Files & Deliverables
FDR-Filtered Immunopeptidome List (.tsv), NetMHCpan Binding & Presentation Scores (.csv), Ranked Tumor Neoantigen Candidates (.pdf/.tsv).
Core Software Toolchain & Frameworks
MSFragger (non-specific digestion), MHCquant, NetMHCpan-4.1, NetMHCIIpan-4.3, MHCflurry 2.0, MuPeXI, nf-core/mhcquant.
Key Literature & Methodological References
Bichmann et al. (2019) Molecular & Cellular Proteomics (MHCquant); Reynisson et al. (2020) Nucleic Acids Research (NetMHCpan-4.1); O'Donnell et al. (2020) Cell Systems (MHCflurry).
Application
“Developing personalized cancer vaccines, TCR-engineered T cells, or bispecific T-cell engagers depends on proving that mutated tumor peptides are genuinely processed and presented on surface HLA molecules. Our Immunopeptidomics and Neoantigen Discovery pipeline combines custom sample-specific variant proteomes with non-tryptic MS/MS searching in MHCquant and MSFragger, paired with ensemble binding affinity predictions from NetMHCpan-4.1 and MHCflurry 2.0. We filter out self-peptides expressed in healthy tissues and rank high-confidence, immunogenic tumor neoantigens ready for vaccine formulation or TCR screening.”
DOMAIN: PROTEOMICS, METABOLOMICS & MULTI-OMICS
PIPELINE #054
Untargeted LC-MS/MS Metabolomics & Lipidomics Annotation Pipeline
Technical Scope: Peak picking, retention time alignment, adduct/isotope grouping, MS2 spectral library matching, and statistical pathway mapping.
Required Input Data & Formats
LC-MS/MS Raw Files (.mzML), Pooled QC & Blank Injections, Sample Metadata (.csv), Spectral Libraries (GNPS, MassBank, NIST, LipidBlast).
Produced Output Files & Deliverables
QC-Normalized Feature Intensity Matrix (.tsv), Annotated Metabolite & Lipid Identification Table (.csv), PLS-DA & Differential Metabolite Plots (.pdf), MetaboAnalyst Pathway Report.
Core Software Toolchain & Frameworks
MZmine 3, XCMS, MS-DIAL, SIRIUS 5 / CSI:FingerID, GNPS, MetaboAnalystR, lipidr.
Key Literature & Methodological References
Schmid et al. (2023) Nature Biotechnology (MZmine 3); Dührkop et al. (2019) Nature Methods (SIRIUS 4/5); Pang et al. (2024) Nucleic Acids Research (MetaboAnalyst).
Application
“Untargeted metabolomics and lipidomics provide a direct biochemical readout of cellular physiology, drug metabolism, and microbiome-host interactions—yet redundant adducts and unannotated spectral features often obscure biological interpretation. Our Untargeted LC-MS/MS pipeline leverages MZmine 3 and MS-DIAL for retention-time alignment, blank subtraction, and pooled-QC drift correction, followed by MS2 spectral matching and in silico molecular formula and structure prediction via SIRIUS 5. We map annotated metabolites onto KEGG and SMPDB biochemical pathways, delivering clean biomarker panels and mechanistic metabolic insights.”
DOMAIN: PROTEOMICS, METABOLOMICS & MULTI-OMICS
PIPELINE #055
13C/15N Stable Isotope Tracing & Metabolic Flux Analysis (MFA)
Technical Scope: Natural isotope abundance correction, mass isotopomer distribution (MID) quantification, and intracellular metabolic pathway flux modeling.
Required Input Data & Formats
Isotope-Labeled LC-MS/GC-MS Files (.mzML), Unlabeled Control Samples, Tracer Labeling Scheme & Stoichiometric Network Model (.csv/.xml).
Produced Output Files & Deliverables
Corrected Mass Isotopomer Distribution (MID) Tables (.tsv), Fractional Contribution & Pathway Flux Maps (.pdf/.svg), Differential Flux Statistics.
Core Software Toolchain & Frameworks
IsoCor, El-MAVEN, AccuCor, Escher-Trace, INCA, FluxFix.
Key Literature & Methodological References
Millard et al. (2019) Bioinformatics (IsoCor); Su et al. (2017) Analytical Chemistry (AccuCor); Young (2014) Bioinformatics (INCA).
Application
“Static metabolite concentrations cannot tell you whether a pathway is hyperactive or blocked at a downstream bottleneck. Stable isotope tracing using 13C-glucose, 13C-glutamine, or 15N-tracers measures actual metabolic flux through glycolysis, the TCA cycle, and nucleotide biosynthesis. Our Metabolic Flux Analysis pipeline processes raw labeling data through El-MAVEN and IsoCor to correct for natural isotope abundance, calculate fractional enrichment across isotopomers, and map flux distributions onto interactive Escher pathway diagrams—pinpointing metabolic vulnerabilities for oncology and immunometabolism drug discovery.”
DOMAIN: PROTEOMICS, METABOLOMICS & MULTI-OMICS
PIPELINE #056
Targeted Affinity Proteomics (Olink PEA / SomaScan) Biomarker Modeling
Technical Scope: NPX/RFU quality control, bridge-sample normalization across plates, mixed-effects differential protein modeling, and machine-learning biomarker panels.
Required Input Data & Formats
Olink NPX Export (.parquet/.csv) or SomaScan ADAT Files (.adat), Clinical & Longitudinal Covariate Metadata (.csv).
Produced Output Files & Deliverables
Bridge-Normalized Protein Matrix (.tsv), Linear Mixed-Effects Association Tables (.csv), LASSO/ElasticNet Biomarker Signatures & ROC Curves (.pdf).
Core Software Toolchain & Frameworks
OlinkAnalyze, SomaDataIO, limma, lme4, glmnet, tidymodels, pROC.
Key Literature & Methodological References
Wik et al. (2021) Molecular & Cellular Proteomics (Olink PEA); Candia et al. (2022) Scientific Reports (SomaScan).
Application
“High-plex affinity proteomics platforms like Olink Explore and SomaScan measure thousands of low-abundance cytokines, growth factors, and disease biomarkers from microliters of plasma—making them indispensable for clinical trials. Our Targeted Affinity Proteomics pipeline executes rigorous QC flagging, bridge-sample normalization across plates and lots via OlinkAnalyze and SomaDataIO, and longitudinal mixed-effects modeling. We then apply regularized machine learning (ElasticNet and Random Forest) with nested cross-validation to derive parsimonious, clinical-grade predictive biomarker panels with validated ROC-AUC performance.”
DOMAIN: PROTEOMICS, METABOLOMICS & MULTI-OMICS
PIPELINE #057
Single-Cell Mass Spectrometry Proteomics (scp / SCoPE2) Analysis
Technical Scope: Carrier-channel ratio normalization, batch-corrected peptide-to-protein aggregation, and single-cell proteomic clustering.
Required Input Data & Formats
DIA-NN or MaxQuant Single-Cell MS Output Tables (.tsv), Cell Sorting & Multiplexed Carrier Design Metadata (.csv).
Produced Output Files & Deliverables
Single-Cell Protein Expression Matrix (.h5ad/.sce), UMAP & Trajectory Plots (.pdf), Differential Single-Cell Protein Abundance Tables (.csv).
Core Software Toolchain & Frameworks
scp (Bioconductor/R), QFeatures, Scanpy, ComBat / limma, scran.
Key Literature & Methodological References
Vanderaa & Gatto (2021) Expert Review of Proteomics (scp); Specht et al. (2021) Genome Biology (SCoPE2); Brunner et al. (2022) Molecular Systems Biology.
Application
“Single-cell mass spectrometry proteomics now quantifies thousands of proteins in individual cells without antibodies, capturing post-transcriptional regulation invisible to scRNA-Seq. However, single-cell MS data presents unique challenges in missingness, carrier-channel interference, and run-to-run drift. Our Single-Cell Proteomics pipeline leverages the Bioconductor scp and QFeatures architecture to filter low-confidence PSMs, normalize against carrier or label-free baselines, aggregate peptides to proteins via robust summarization, and integrate single-cell proteomes with scRNA-Seq atlases.”
DOMAIN: PROTEOMICS, METABOLOMICS & MULTI-OMICS
PIPELINE #058
Unsupervised Multi-Omics Latent Factor Integration (MOFA+ / DIABLO)
Technical Scope: Joint matrix factorization and supervised discriminant integration across genomics, transcriptomics, proteomics, metabolomics, and microbiome layers.
Required Input Data & Formats
Sample-Matched Normalized Matrices for 2+ Omics Modalities (.tsv/.csv), Clinical Subtype or Outcome Metadata (.csv).
Produced Output Files & Deliverables
Trained MOFA2/DIABLO Model (.hdf5/.rds), Variance Explained per Factor & Modality Plots (.pdf), Top Multi-Omic Feature Weights (.csv), Patient Subtype Clusters.
Core Software Toolchain & Frameworks
MOFA2 (MOFA+), mixOmics (DIABLO), SNF (Similarity Network Fusion), iClusterPlus, Muon.
Key Literature & Methodological References
Argelaguet et al. (2020) Genome Biology (MOFA+); Singh et al. (2019) Bioinformatics (DIABLO); Wang et al. (2014) Nature Methods (SNF).
Application
“Analyzing each omics dataset in isolation misses coordinated biological signals that span DNA methylation, mRNA transcription, protein abundance, and circulating metabolites. Our Multi-Omics Integration pipeline combines unsupervised Bayesian factor analysis in MOFA+ with supervised multi-block discriminant modeling in mixOmics DIABLO. We disentangle shared biological drivers from modality-specific technical variation, stratify patients into clinically meaningful molecular subtypes, and extract concise cross-omic biomarker signatures—transforming fragmented multi-omic cohorts into unified systems-level insights.”
DOMAIN: PROTEOMICS, METABOLOMICS & MULTI-OMICS
PIPELINE #059
Cross-Linking Mass Spectrometry (XL-MS) & Protein Complex Topology Modeling
Technical Scope: Identification of intra- and inter-protein cross-linked peptide pairs, FDR estimation, and spatial distance restraints for structural modeling.
Required Input Data & Formats
Cross-Linked MS Raw Files (.raw/.mzML), Cleavable/Non-Cleavable Cross-Linker Definition (e.g., DSSO, BS3), Protein Complex FASTA (.fasta) & PDB Structures (.pdb).
Produced Output Files & Deliverables
FDR-Filtered Cross-Link Pair Table (.tsv), 2D Protein Interaction Network Map (.svg/.pdf), 3D Structural Distance Validation on PDB Models (.py/.pse).
Core Software Toolchain & Frameworks
MSAnnika, xiSEARCH / xiFDR, pLink 2, Kojak, xiVIEW, ChimeraX / PyMOL.
Key Literature & Methodological References
Pirklbauer et al. (2021) Journal of Proteome Research (MSAnnika); Fischer & Rappsilber (2017) Analytical Chemistry (xiFDR); Liu et al. (2017) Nature Communications (pLink 2).
Application
“Understanding how multi-subunit protein complexes assemble and change conformation in solution is essential for allosteric drug discovery and antibody epitope mapping. Our Cross-Linking Mass Spectrometry pipeline processes MS-cleavable and non-cleavable XL-MS datasets using MSAnnika and xiSEARCH/xiFDR to accurately identify intra- and inter-molecular cross-links at strict 1% cross-link-level FDR. We map physical distance restraints directly onto cryo-EM or AlphaFold 3 structures in ChimeraX, validating protein-protein interaction interfaces in their native physiological environment.”
DOMAIN: PROTEOMICS, METABOLOMICS & MULTI-OMICS
PIPELINE #060
Imaging Mass Spectrometry (MALDI-MSI) Spatial Metabolomics & Histology Co-Registration
Technical Scope: Spatial spectral peak picking, TIC/RMS normalization, co-registration with H&E histology, and spatial segmentation of metabolites and drugs.
Required Input Data & Formats
imzML + ibd Imaging Mass Spectrometry Files (.imzML/.ibd), Co-Registered H&E/IF Microscopy Image (.tif/.ome.tif), Region of Interest Annotations (.geojson).
Produced Output Files & Deliverables
Normalized Spatial Ion Intensity Cube (.rds/.h5), Spatial Segmentation & Drug Distribution Maps (.pdf/.png), ROI Differential Metabolite Table (.csv).
Core Software Toolchain & Frameworks
Cardinal (R/Bioconductor), SCiLS Lab / METASPACE, SpatialData, pyimzML, QuPath.
Key Literature & Methodological References
Bemis et al. (2023) Nature Methods (Cardinal 3); Palmer et al. (2017) Nature Methods (METASPACE).
Application
“Imaging Mass Spectrometry maps the spatial distribution of endogenous metabolites, lipids, and small-molecule drugs directly across unlabelled tissue sections without antibodies or tags. Our MALDI-MSI Spatial Metabolomics pipeline uses Cardinal 3 and METASPACE to perform baseline correction, total-ion-current normalization, and precise co-registration with serial H&E pathology annotations from QuPath. Quantify drug penetration into necrotic tumor cores, map spatial metabolic heterogeneity, and discover region-specific lipid biomarkers with micrometer spatial precision.”
Back to Workflows